SpringerLink
Log in

Methylprednisolone Administration in Primary Biliary Cirrhosis Increases Cholic Acid Turnover, Synthesis, and Deoxycholate Concentration in Bile

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

As immunosuppressive agents, corticosteroids maybe considered an appropriate treatment for primarybiliary cirrhosis, even if bone loss and other sideeffects may occur. We studied biliary lipid metabolism in 10 nonicteric patients, with histologicallyproven primary biliary cirrhosis (stage I-IV). Weadministered methylprednisolone (24 mg daily) for 30days to ascertain its effects on biliary lipidmetabolism, which are largely still unknown. All patientsunderwent a 30-day drug-washout period before enteringthe trial. The following parameters were studied beforeand after methylprednisolone treatment: serum biochemistry; cholic acid pool size, kineticsand synthesis; biliary lipid secretion; biliary bileacid pattern; biliary lipid molar percentage; andcholesterol saturation index. Methylprednisolone induced a statistically significant (Wilcoxon ranktest) increase in cholic acid turnover (from 0.26± 0.04 to 0.50 ± 0.05 K/day, P = 0.005)and synthesis (from 0.42 ± 0.12 to 0.78 ±0.11 mmol/day, P = 0.04), and in bile deoxycholic acid molarpercentage (from 19.4 ± 2.7 to 30.6 ± 4.4%molar, P = 0.01). On the other hand, a significantdecrease in biliary cholesterol molar percentage (from7.9 ± 0.7 to 6.4 ± 0.5 % molar, P =0.005), cholesterol saturation index (from 1.11 ±0.11 to 0.95 ± 0.07, P = 0.05), and biliarycholesterol secretion (from 64.7 ± 5.4 to 53.0± 4.5 μmol/hr, P = 0.005) was observed. These findings show thatshort-term administration of methylprednisolone inpatients with primary biliary cirrhosis does not induceexpansion of the cholic acid pool but increases cholicacid synthesis and turnover, as well as intestinalproduction of deoxycholic acid. If long-term treatmentis considered, the beneficial immunosuppressive effectsof corticosteroids have to be weighed against the hepatotoxic properties of deoxycholicacid.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Kaplan MM: Primary biliary cirrhosis. N Engl J Med 316:521–528, 1987

    Google Scholar 

  2. James SP, Hoofnagle JH, Strober W, Jones EA: Primary biliary cirrhosis: A mode l autoimmune disease. Ann Intern Med 99:500–512, 1983

    Google Scholar 

  3. James SP, Elson CO, Jones EA, Strobert W: Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis. Gastroenterology 79:242–254, 1980

    Google Scholar 

  4. Bjorkland A, Totterman TH: Is primary biliary cirrhosis an autoimmune disease? Scand J Gastroenterol 29(suppl 204):32–39, 1994

    Google Scholar 

  5. Hofmann AF, Popper H: Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 2:398–399, 1987

    Google Scholar 

  6. Matloff DS, Alpert E, Resnick RH, Kaplan MM: A prospective trial of D-penicillamine in primary biliary cirrhosis. N Engl J Med 306:319–326, 1982

    Google Scholar 

  7. Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, Doniach D, Ranek L, Tygstrup N, Williams R: Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Gastroenterology 89:1084–1091, 1985

    Google Scholar 

  8. Kaplan MM, Alling DW, Zimmerman HJ, Wolfe HJ, Sepersky RA, Hirsch GS, Elta GH, Glick KA, Eagen KA: A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med 315:1448–1454, 1986

    Google Scholar 

  9. Lombard M, Portmann B, Neuberger J, Williams R, Tygstrup N, Ranek L, Ring-Larsen H, Rodes J, Navasa M, Trepo C, Pape G, Schou G, Badsberg JH, Andersen PK: Cyclosporin A treatment in primary biliary cirrhosis: Re sults of a long term placebo controlled trial. Gastroenterology 104:519–526, 1993

    Google Scholar 

  10. Wiesner RH, Grambsch PM, Lindor KD, Ludwig J, Dickson ER: Clinical and statistical analyse s of new and evolving therapies for primary biliary cirrhosis. Hepatology 8:668–676, 1988

    Google Scholar 

  11. Poupon RE, Lindor KD, Cauc-Dudek K, Dickson ER, Poupon R, Heathcote EJ: Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 113:884–890, 1997

    Google Scholar 

  12. Beukers R, Schalm SW: Immunosuppressive therapy for primary biliary cirrhosis. J Hepatol 14:1–6, 1992

    Google Scholar 

  13. Mitchison HC, Palmer JM, Bassendine MF, Watson AJ, Record CO, James OFW: A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J Hepatol 15:336–344, 1992

    Google Scholar 

  14. Duncan Phillips J, Stelzner M, Zeng H, Kelly RE, Fonkalsrud EW: Alterations in gastrointestinal motility during postoperative acute corticosteroid withdrawal. Am J Surg 162:251–255, 1991

    Google Scholar 

  15. Wolfhagen FH, van Buuren HR, Schalm SW: Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis. Neth J Med 44:84–90, 1994

    Google Scholar 

  16. Leuschner M, Guldutuna S, You T, Hubner K, Bhatti S, Leuschner U: Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J Hepatol 25:49–57, 1996

    Google Scholar 

  17. Grundy SM, Metzger AL: A physiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology 62:1200–1217, 1972

    Google Scholar 

  18. Mazzella G, Parini P, Festi D, Bazzoli F, Aldini R, Roda A, Tonelli D, Cipolla A, Salzetta A, Roda E: Effect of simvastatin, ursodeoxycholic acid, and simvastatin and ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in non-familial hype rcholesterolemia. Hepatology 15:1072–1078, 1992

    Google Scholar 

  19. Mazzella G, Bazzoli F, Villanova N, Simoni P, Festi D, Roda A, Aldini R, Roda E: Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients: A crossover study with clofibrate. Scand J Gastroenterol 25:1227–1234, 1990

    Google Scholar 

  20. Roda A, Festi D, Sama C, Mazzella G, Aldini R, Roda E, Barbara L: Enzymatic determination of cholesterol in bile. Clin Chim Acta 64:377–381, 1975

    Google Scholar 

  21. Talalay P: Enzymatic analysis of steroid hormones. Methods Biochem Ann 8:119–143, 1960

    Google Scholar 

  22. Svamborg A, Svennerholm M: Plasma total lipid cholesterol, tryglice rides, phospholipids and free fatty acids in healthy scandinavian population. Acta Med Scand 169:43–49, 1961

    Google Scholar 

  23. Abell LL, Levy BB, Bride BB. Cholesterol in serum. In Standard Methods of Clinical Chemistry, Vol 2. D Saligson (ed). New York, Academic Press, 1958, pp 26–33

    Google Scholar 

  24. Hyden S: A turbidimetric method for determination of higher polyethylenglycols in biological materials. Ann R Agric Coll Swed 22:139–149, 1955

    Google Scholar 

  25. Roda A, Cerré C, Simoni P, Polimeni C, Vaccari C, Pistillo A: Determination of free and amidated bile acids by HPLC with evaporative light-scattering mass dete ction. J Lipid Res 33:1393–1402, 1992

    Google Scholar 

  26. Carey MC, Small DM: The physical chemistry of cholesterol solubility in bile: Relationship to gallstone formation and dissolution in man. J Clin Invest 61:998–1026, 1978

    Google Scholar 

  27. Carey MC: Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 19:945–955, 1978

    Google Scholar 

  28. Lindstedt S: The turnover of cholic acid in man. Acta Physiol Scand 40:1–9, 1957

    Google Scholar 

  29. Stellaard F, Sackmann M, Sauerbruch T, Paumgartner G: Simultaneous determination of cholic acid and chenodeoxycholic acid pool sizes and fractional turnover serum in human se rum using 13C-labeled bile acids. J Lipid Res 25:1313–1319, 1984

    Google Scholar 

  30. Glantz SA: Primer of Biostatistics. New York, McGraw-Hill, 1987

    Google Scholar 

  31. Lim AG, Jazrawi RP, Northfield TC: The ursodeoxycholic acid story in primary biliary cirrhosis. Gut 37:301–304, 1995

    Google Scholar 

  32. Princen HMG, Meijer P, Hofstee B: Dexame thasone regulated bile acid synthe sis in monolayer cultures of rat hepatocytes by induction of cholesterol 7α-hydroxylase. Biochem J 262:341–348, 1989

    Google Scholar 

  33. Vlahcevic ZR, Pandack WM, Heuman DM, Hylemon PB: Function and regulation of hydroxylases involved in the bile acid biosynthesis pathways. Semin Liver Dis 12:403–419, 1992

    Google Scholar 

  34. Carulli N, Loria P, Bertolotti M, Ponz de Leon M, Menozzi D, Medici G, Piccagli I: Effects of acute changes of bile acid pool composition on biliary lipid secretion. J Clin Invest 74:614–624, 1984

    Google Scholar 

  35. Roda E, Mazzella G, Bazzoli F, Villanova N, Minutello A, Simoni P, Ronchi M, Poggi C, Festi D, Aldini R, Roda A: Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis. Dig Dis Sci 34: 52S-58S, 1989

    Google Scholar 

  36. Mazzella G, Parini P, Bazzoli F, Villanova N, Festi D, Aldini R, Roda A, Cipolla A, Polimeni C, Tonelli D, Roda E: Ursode-oxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis. Dig Dis Sci 38:896–902, 1993

    Google Scholar 

  37. Roda E, Aldini R, Mazzella G, Roda A, Sama C, Festi D, Barbara L: Enterohepatic circulation of bile acids after cholecystectomy. Gut 19:640–649, 1978

    Google Scholar 

  38. Guldutuna S, Leuschner M, Wunderlich N, Nickel A, Bhatti S, Hubner K, Leuschener U: Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function. Eur J Clin Pharmacol 45:221–225, 1993

    Google Scholar 

  39. Marcus SN, Heaton KW: Intestinal Transit, deoxycholic acid and the cholesterol saturation of bileÐ three interre lated factors. Gut 27:550–558, 1986

    Google Scholar 

  40. Barr F, Pratschke E, Fisher S, Paumgartner G: Disorde rs of bile acid metabolism in cholesterol gallstone disease. J Clin Invest 90:859–868, 1992

    Google Scholar 

  41. Angelin B, Einarsson K, Leijd B: Biliary lipid composition during treatment with different hypolipidaemic drugs. Eur J Clin Invest 9:185–190, 1977

    Google Scholar 

  42. Carrella M, Ericsson S, Del Piano C, Angelin B, Einarsson K: Effect of cholestyramine treatment on biliary lipid secretion rated in normolipidaemic men. J Int Med 229:241–246, 1991

    Google Scholar 

  43. Ettinger WH Jr, Hazzard WR: Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism 37:1055–1058, 1988

    Google Scholar 

  44. Jefferys DB, Lessof MH, Mattock MB: Corticosteroid treatment, serum lipids and coronary artery disease. Postgrad Med 56:491–493, 1980

    Google Scholar 

Download references

Authors
  1. Giuseppe Mazzella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pietro Fusaroli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessandro Pezzoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesco Azzaroli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Costanza Mazzeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Laura Zambonin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Patrizia Simoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Davide Festi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Enrico Roda
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mazzella, G., Fusaroli, P., Pezzoli, A. et al. Methylprednisolone Administration in Primary Biliary Cirrhosis Increases Cholic Acid Turnover, Synthesis, and Deoxycholate Concentration in Bile. Dig Dis Sci 44, 2478–2483 (1999). https://doi.org/10.1023/A:1026687022202

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026687022202

Search

Navigation